Module

The Virus, the Tissues and Immune Activation: What Makes HIV Infection Pathogenic?

Source: HIV/AIDS Annual Update 2009

The Virus, the Tissues and Immune Activation: What Makes HIV Infection Pathogenic?

Program Director: W. David Hardy, MD

Faculty:

Daniel Douek, MD, MRCP, PhD

CREDIT INFORMATION

Release Date: May 22, 2009

Expiration Date: May 21, 2010

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.7 Nursing contact hours

Pharmacists: 0.7 contact hours (0.07 CEUs)

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the depletion of CD4+ T cells in the gastrointestinal tract following HIV-1 infection
Discuss immune activation following HIV-1 infection and its effects on the T-cell population in the gastrointestinal tract
Explain how early HAART may have a greater effect on repopulating the CD4+ T-cell population in the gut than treatment during chronic infection

Topics covered include:

GI Tract Damage in HIV-1 Infection
Consequences of Immune Activation
Progression to AIDS
HAART and the GI Tract
GI Damage in Nonprogressive Infection
Summary: Implications for Clinical Practice

Abstract

Click here to view abstract

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.